Kodif announces strategic partnership with Halo Collar after already automating 75% of customer support chatbot tickets
SUNNYVALE, Calif., Sept. 18, 2024 /PRNewswire/ — Kodif, a leading provider of customer experience automation solutions, is thrilled to announce its strategic partnership with Halo Collar. Kodif, a customer support automation platform powered by GenAI, is designed to resolve the most…
VIDAA is chosen by Vestel as one of its strategic platforms, with Vestel acquiring a 4.64% stake in company
ATLANTA, Sept. 18, 2024 /PRNewswire/ — Vestel announced today that it has partnered with VIDAA as one of its strategic platforms for recurring revenues by signing an MoU to acquire a 4,64% ownership stake in the fastest growing Smart TV platform in the world. The acquisition will…
RLDatix Acquires SocialClimb, Empowering Healthcare Organizations with Enhanced Provider Reputation Management and Patient Experience Data Insights
With a heritage in safety, RLDatix expands its suite of connected healthcare operations solutions to equip healthcare organizations with a 360-degree view of providers, patient safety and care quality. CHICAGO, Sept. 18, 2024 /PRNewswire/ — RLDatix, the leading global provider of…
Asset Managers Broadly Continue Growth in Q2 2024, Private Markets Firms Continue to Lead the Way: Casey Quirk
NEW YORK and STAMFORD, Conn., Sept. 18, 2024 /PRNewswire/ — According to new research from global asset management strategy consultant Casey Quirk, a Deloitte business, publicly listed asset managers saw strong growth from Q2 2023 to Q2 2024, continuing an overall positive trend despite…
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of 420mg Strength of HERCESSI⢠(trastuzumab-strf), a biosimilar to Herceptin® (trastuzumab), for the Treatment of Several Forms of HER2-Overexpressing Cancer
FDA approval of a second strength for HERCESSI paves the way for Accord BioPharma to prepare to commercially launch its first biosimilar; several others are in active development DURHAM, N.C., Sept. 18, 2024 /PRNewswire/ — Accord BioPharma, Inc., the U.S. specialty division of Intas…
BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak⢠XtraFlow⢠Glass Prefillable Syringe and the latest capacity expansion of the BD Neopak⢅
The Bosselman Enterprises Promotes Jake England to Director of Boss Truck Shops
GRAND ISLAND, Neb., Sept. 17, 2024 /PRNewswire/ — The Bosselman Enterprises is proud to announce the promotion of Jake England to Director of Boss Truck Shops. In his new role, Jake will oversee the operations of Boss Truck Shops across its network, ensuring the highest level of service…
Thermo Compression Forming Market worth $13.37 billion by 2029 – Exclusive Report by MarketsandMarketsâ¢
DELRAY BEACH, Fla., Sept. 18, 2024 /PRNewswire/ — The report “Thermo Compression Forming Market by Foam Type (Thermoplastic Foam, Needle-Punch Nonwovens, Light Weight Glass Mat Thermoplastic), End-use Industry (Automotive, Aerospace, Construction, Medical, Electrical & Electronics) -…
AIRS Medical Partners with MXR Imaging to Bring SwiftMR⢠to More Than 300 Radiology Practices
SEOUL, South Korea, Sept. 18, 2024 /PRNewswire/ — AIRS Medical has partnered with MXR Imaging, the largest independent distributor of medical imaging equipment in the United States, to deliver SwiftMR⢠to more than 300 radiology practices nationwide. This partnership empowers diagnostic…
Biosyngen’s first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress
BARCELONA, Spain, Sept. 18, 2024 /PRNewswire/ — The highly anticipated 2024 European Society for Medical Oncology (ESMO) Annual Congress has taken place in Barcelona, Spain. As one of the most influential annual gatherings in oncology, this congress brings together leading cancer experts…